LauraMauriMD
Cardiology • Boston, MAAdult Congenital Heart Disease, Heart Failure & Transplantation, Interventional Cardiology
Associate Professor of Medicine, Brigham and Women's Hospital
Are you Dr. Mauri?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 58 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1620 Tremont St
Brighams and Womens Hospital Div of Clinical Biometrics
Boston, MA 02120Phone+1 617-732-8936Fax+1 617-525-8027
Summary
- Dr. Laura Mauri, MD is a cardiologist in Boston, Massachusetts. She is currently licensed to practice medicine in Massachusetts. She is an Associate Professor of Medicine at Brigham and Women's Hospital.
Education & Training
Brigham and Women's HospitalFellowship, Cardiovascular Disease, 1999 - 2002
Harvard Medical SchoolClass of 1996
Certifications & Licensure
MA State Medical License 1998 - 2025
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Randomized Study Comparing Endeavor With Cypher Stents (PROTECT) Start of enrollment: 2007 Jun 01
- The Medtronic RESOLUTE US Clinical Trial Start of enrollment: 2008 Jul 01
- PERVIDEO I Registry, The Lutonix Paclitaxel-Coated Balloon Catheter for the Treatment of Coronary In-Stent Restenosis Start of enrollment: 2009 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 136 citations2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial Infarction: An update of the 2011 ACCF/AHA/SCA...Glenn N. Levine, Eric R. Bates, James C. Blankenship, Steven R. Bailey, John A. Bittl
Catheterization and Cardiovascular Interventions. 2016-05-01 - 879 citations2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive SummaryDonna K. Arnett, Roger S. Blumenthal, Michelle A. Albert, Erin D. Michos, Andrew B. Buroker
Journal of the American College of Cardiology. 2019-03-17 - 198 citationsChallenges in the Design and Interpretation of Noninferiority TrialsLaura Mauri, Ralph B. D'Agostino
The New England Journal of Medicine. 2017-10-04
Authored Content
- 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical TrialsMarch 2017
Press Mentions
Representation Matters in Clinical TrialsFebruary 13th, 2023- Positive Airway Pressure Devices Market Report- Top Manufacturers and Future Growth | Airing LLC, Beijing Dehaier Medical Technology Co LtdMay 11th, 2021
- 2020 MIS Devices Market Report- Size, Business Opportunities, Segmentation and Regional OverviewSeptember 19th, 2020
- Join now to see all
Professional Memberships
- Member
